Brote familiar por el nematodo Trichostrongylus colubriformis en una zona rural de la provincia de Valdivia: una zoonosis de rara ocurrencia / Family outbreak caused by the nematode Trichostrongylus colubriformis in a rural area of the province of Valdivia: a rare occurrence zoonoses

Resumen La trichostrongylosis es una zoonosis de rara ocurrencia causada por nematodos intestinales, favorecida por el consumo de vegetales crudos o agua contaminada con larvas infectantes de Trichostrongylus spp. En 2015, se registró un brote familiar transmitido por alimentos en una zona rural de Valdivia, afectando a una mujer de 51 años de edad y su pareja e hija de 56 y 12 años; respectivamente. Solo la mujer adulta, el caso índice, presentó síntomas como diarrea, dolor abdominal, astenia y náuseas. Los pacientes eliminaron huevos de Trichostrongylidae gen. sp. en sus deposiciones, identificándose en dos de ellos, adultos de Trichostrongylus colubriformis. Tuvieron una buena respuesta a albendazol. En Chile, se han registrado prevalencias de infección de 0,1 a 3,5%, incluyendo un total de 93 casos diagnosticados entre las provincias de Concepción y Llanquihue.

Abstract Trichostrongylosis is a rare occurrence zoonosis caused by intestinal nematodes, favored by the consumption of raw vegetables or water contaminated with infective larvae of Trichostrongylus spp. In 2015, a family outbreak of foodborne disease was registered in a rural zone of Valdivia, affecting to 51-year-old woman and her 56-year-old partner and her 12-year-old daughter. Only the adult woman, the index case, presented symptoms such as diarrhea, abdominal pain, asthenia, and nausea. The patients revealed Trichostrongylidae gen. sp. eggs in their stools, identifying Trichostrongylus colubriformis adults in two of them. They had a good response to treatment with albendazol. In Chile, 0.1 to 3.5% prevalence of infection has been reported, including a total of 93 cases recorded between the provinces of Concepción and Llanquihue.

Communicating branches between the median and ulnar nerves: proposal for inclusion in terminologia anatomica / Ramos comunicantes entre los nervios mediano y ulnar: propuesta de inclusión en terminologia anatomica

The ulnar and median nerves are widely distributed, innervating the muscles of the forearm and hand. In the latter, it also registers the sensitivity of a significant part of the skin. A series of communicating branches (CB) is described on the path of these nerves, including: 1) the Martin-Gruber communicating branch, 2) the Marinacci communicating branch, 3) the Riché-Cannieu communicating branch and 4) the Berrettini communicating branch. The aim of this study was to establish a correct denomination of these CB, using Latin and eliminating the use of eponyms. The exploratory study included books on anatomy and scientific articles that detailed the anatomical aspects of these CB. To these were added the terms that these branches presented in the various anatomical lists and terminologies. Each term proposal was done in Latin, using the corresponding gender, number and case. The CB between the median and ulnar nerves are described in anatomy texts as well as a plethora of publications. The prevalence rates of the CB range between 1.7 and 94 %; however, their inclusion in the anatomical terminologies has been limited. Based on the description of these branches and the presence of some of them in the existing terminologies, a proposal was prepared in line with the indications of the Federative International Programme on Anatomical Terminologies (FIPAT): 1) Ramus comunicans cum nervo ulnari, 2) Ramus comunicans cum nervo mediano, 3) Ramus communicans cum ramo profundo nervi ulnaris y 4) Ramus communicans cum nervo digitali palmari communi. Considering that terminologies are dynamic linguistic corpora, it is important to analyze constantly the incorporation of new terms that are in harmony with the scientific findings. The incorporation of new structures must follow FIPAT guidelines and include the grammatical aspects of Latin.

Los nervios ulnar y mediano presentan una amplia distribución que permite inervar músculos del antebrazo y mano, en esta última, también registran la sensibilidad de un importante territorio cutáneo. En el recorrido de estos nervios se describen una serie de ramos comunicantes (RC), entre los cuales destacan: 1) Ramo comunicante de Martin-Gruber 2) Ramo comunicante de Marinacci 3) Ramo comunicante de Riché-Cannieu y 4) Ramo comunicante de Berretini. El propósito de este trabajo fue establecer una correcta denominación de estos RC, usando para ello el latín y eliminando el uso de epónimos. El estudio exploratorio incluyó libros de anatomía y artículos científicos que detallaran los aspectos anatómicos de estos RC. A lo anterior se sumaron los términos que estos ramos presentaron en las diversas nóminas y terminologías anatómicas. Cada propuesta de denominación se realizó en latín, utilizando el género, número y caso correspondiente. Los RC entre los nervios mediano y ulnar se encuentran descritos tanto en textos de anatomía como en un sinnúmero de publicaciones. Las tasas de prevalencia de los RC fluctúan entre 1,7 y 94 %; a pesar de ello; su inclusión en las terminologías anatómicas ha sido limitado. En base a la descripción de éstos ramos y la presencia de algunos de ellos en las terminologías existentes, se elaboró una propuesta alineada con las indicaciones del Programa Federativo Internacional de Terminología Anatómica (FIPAT): 1) Ramus comunicans cum nervo ulnari, 2) Ramus comunicans cum nervo mediano, 3) Ramus communicans cum ramo profundo nervi ulnaris y 4) Ramus communicans cum nervo digitali palmari communi. Considerando que las terminologías son cuerpos lingüísticos dinámicos, resulta importante analizar constantemente la incorporación de nuevos términos que se encuentren en sintonía con los hallazgos científicos. La incorporación de nuevas estructuras debe seguir los lineamientos de FIPAT y considerar los aspectos gramaticales del latín.

Brotes de enfermedades transmitidas por alimentos y agua en la Región Metropolitana, Chile (2005-2010) / Foodborne disease outbreaks around the urban Chilean areas from 2005 to 2010

Background: Foodborne disease outbreaks are one of the main health problems all over the world, which have an extensive impact on human health. Objetive: To analyze the foodborne disease outbreaks occurred in Chilean urban area from 2005 to 2010. Methods: We made a descriptive epidemiologic study. First, criteria were defined and classified according to previous epidemiologic investigations, clinical and environment samples, then. Variables of space, time, place and person were also analyzed. Results: Among 2,806 reported outbreaks, 2434 (86.7%) fulfilled the inclusion criteria. Incidence rate of the period (2005-2010) were 32 cases per 100 inhabitants. A total of 12,196 people were affected, with an average of 5 patients per outbreak. The households (36.2%), restaurants (16.3%), supermarkets (6.3%) free fair (4.4%) have been the most important outbreak areas. The foods involved were seafood (15.4%), fish (15.1%), and fast food (13.5%). The etiologic agents were Salmonella spp, Shigella spp, Vibrio parahaemolyticus. Conclusions: Outbreaks foodborne diseases are frequents in the Chilean urban area, which make vulnerable a lot of people. The largest numbers happened in the households and were due to bad handling and/or inappropriate storage of the foods.

Antecedentes: Las enfermedades transmitidas por alimentos (ETA) constituyen en el ámbito mundial, uno de los problemas sanitarios más comunes y de mayor impacto sobre la salud de las personas. Objetivo: Analizar los brotes de ETA notificados en la Región Metropolitana (RM) de Chile entre enero 2005 y junio 2010. Material y Métodos: Estudio epidemiológico descriptivo de base de datos de brotes de ETA que se clasificaron de acuerdo a encuesta epidemiológica y muestra clínica o ambiental. Se analizaron variables de espacio, tiempo, lugar y persona. Resultados: De los 2.806 brotes notificados, 2.434 (86,7%) cumplieron con los criterios de inclusión. Un total de 12.196 personas fueron afectadas, con un promedio de 5 enfermos por brote. La tasa de incidencia del período 2005-2010 fue 32 casos por 100 habitantes Los ámbitos de mayor brote fueron los hogares (36,2%), restaurantes (16,3%), supermercados (6,3%), ferias libres (4,4%). Los alimentos involucrados fueron mariscos (15,4%), pescados (15,1%), platos rápidos (13,5%). Los principales agentes etiológicos investigados fueron Salmonella spp, Shigella spp y Vibrio parahemolyticus. Conclusiones: Los brotes de ETA son muy frecuentes en la RM, comprometiendo un gran número de personas. La mayoría se produjeron en los hogares y fueron provocados por mala manipulación y/o conservación de los alimentos.

Evaluación de un test comercial de avidez de IgG: Aporte al diagnóstico de primoinfección por Toxoplasma gondii / Evaluation of an IgG avidity commercial test: Contribution to diagnosis of primary infection caused by Toxoplasma gondii

Introduction: Toxoplasmosis (T) is a major chronic parasitic infection in immunocompromised patients and pregnant women. It is important to discriminate between acute phase (AT) and chronic phase (CT). Diagnosis is serological in immunocompetent patients (concentration of IgG and IgM). Objective: To evaluate the utility of an IgG avidity test (A-IgG) to identify the acute and chronic stage. Avidity is the strength of affinity between a specific immunoglobulin and the protein antigenic epitope of the infecting agent, an affinity that increases over time. Patients and Methods: We used a qualitative kit that measures the avidity of IgG, discriminating the two phases. In 35 patients with clinical diagnosis of AT and/or CT, IgG, IgM and IgG A (VIDAS®) were performed. Results: Patients with AT were positive for IgM and IgG, but presented weak avidity. In the 21 cases with CT, 52 percent (n: 11) were IgM positive and 100 percent (n: 21) had positive IgG with strong avidity. Discussion: The results confirm that the test of A-IgG may be useful in the diagnosis of AT, and has 100 percent concordance with reference test (qualitative IgM + quantitative IgG). The result is available within 24 hrs, and may be useful in diagnosis of AT in pregnant women.

Introducción: Toxoplasmosis (T) es una infección parasitaria crónica importante en pacientes inmunocompro-metidos y mujeres embarazadas. Es relevante discriminar entre fase aguda (TA) y fase crónica (TC). Su diagnóstico es serológico en inmunocompetentes (detección de IgG e IgM). Objetivo: Evaluar la utilidad del test de avidez IgG (A-IgG) para identificar la fase aguda y o crónica. Avidez es la fuerza de afinidad entre una inmunoglobulina específica y el epítope de la proteína antigénica del agente infectante, afinidad que aumenta con el tiempo. Pacientes y Métodos: Se usó un test cualitativo que mide la avidez de IgG, discriminando las dos fases. A 35 pacientes con diagnóstico clínico de TA y o TC, se les realizó IgG, IgM e A-IgG en Equipo VIDAS®. Resultados: Los pacientes con TA fueron positivos para IgM e IgG y presentaron avidez débil. Los 21 casos con TC 52 por ciento (n: 11) tuvieron IgM positivo y 100 por ciento (n: 21) tuvo IgG positiva con avidez fuerte. Discusión: Los resultados confirman que el test de A-IgG puede ser de gran utilidad en el diagnóstico de TA, concordancia: 100 por ciento con test de referencia (IgM cualitativa + IgG cuantitativa). El resultado está disponible en menos de 24 hrs, pudiendo ser útil en el diagnóstico de TA en mujeres embarazadas.

Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species

Aspartyl proteases are a class of enzymes that include the yeast aspartyl proteases and secreted aspartyl protease (Sap) superfamilies. Several Sap superfamily members have been demonstrated or suggested as virulence factors in opportunistic pathogens of the genus Candida. Candida albicans, Candida tropicalis, Candida dubliniensis and Candida parapsilosis harbour 10, four, eight and three SAP genes, respectively. In this work, genome mining and phylogenetic analyses revealed the presence of new members of the Sap superfamily in C. tropicalis (8), Candida guilliermondii (8), C. parapsilosis(11) and Candida lusitaniae (3). A total of 12 Sap families, containing proteins with at least 50 percent similarity, were discovered in opportunistic, pathogenic Candida spp. In several Sap families, at least two subfamilies or orthologous groups were identified, each defined by > 90 percent sequence similitude, functional similarity and synteny among its members. No new members of previously described Sap families were found in a Candida spp. clinical strain collection; however, the universality of SAPT gene distribution among C. tropicalis strains was demonstrated. In addition, several features of opportunistic pathogenic Candida species, such as gene duplications and inversions, similitude, synteny, putative transcription factor binding sites and genome traits of SAP gene superfamily were described in a molecular evolutionary context.

Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects

The gut barrier monitors and protects the gastrointestinal tract from challenges such as microorganisms, toxins and proteins that could act as antigens. There is evidence that gut barrier dysfunction may act as a primary disease mechanism in intestinal disorders. The aim of the present study was to evaluate the barrier function towards sugars after the appropriate treatment of celiac disease and Crohn's disease patients and compare the results with those obtained with healthy subjects. Fifteen healthy volunteers, 22 celiac disease patients after 1 year of a gluten-free diet, and 31 Crohn's disease patients in remission were submitted to an intestinal permeability test with 6.0 g lactulose and 3.0 g mannitol. Six-hour urinary lactulose excretion in Crohn's disease patients was significantly higher than in both celiac disease patients (0.42 vs 0.15 percent) and healthy controls (0.42 vs 0.07 percent). Urinary lactulose excretion was significantly higher in celiac disease patients than in healthy controls (0.15 vs 0.07 percent). Urinary mannitol excretion in Crohn's disease patients was the same as healthy controls (21 vs 21 percent) and these values were significantly higher than in celiac disease patients (10.9 percent). The lactulose/mannitol ratio was significantly higher in Crohn's disease patients in comparison to celiac disease patients (0.021 vs 0.013) and healthy controls (0.021 vs 0.003) and this ratio was also significantly higher in celiac disease patients compared to healthy controls (0.013 vs 0.003). In spite of treatment, differences in sugar permeability were observed in both disease groups. These differences in the behavior of the sugar probes probably reflect different mechanisms for the alterations of intestinal permeability.

Evidencia seroepidemiológica de exposición humana a Anaplasma sp en Santiago, Chile / Seroepidemiological evidence of human exposure to Anaplasma sp in Santiago, Chile

Objectives and Methods: To find more evidence of human exposure to Anaplasma sp in Chile, we studied 108 contaets of dogs with canine ehrlichiosis (CE) (risk group) and 61 persons without tick or CE cases contact (control group). A survey including risk factors and history of diseases compatible with ehrlichiosis/ anaplasmosis was applied to the risk group. Serum IgG anti-Anaplasma sp antibodies were determined in both groups. Results: A significant difference was found in the prevalence of anti-Anaplasma sp antibodies in the risk group compared with the control group (18,5 versus 3,3 percent), p < 0,005. No risk factors associated to seropositivity were found, ñor persons with history suggesting ehrlichiosis/anaplasmosis. Ninety four percent of the houses of the risk group had tick infestation. Discussion: A greater risk of exposition to Anaplasma sp is documented in people living in cióse contact with CE cases and in houses with tick infestation.

Objetivos y Método: Con el propósito de buscar mayor evidencia de exposición humana a Anaplasma sp en Chile, se estudiaron 108 personas en contacto con perros con ehrlichiosis canina (EC) (grupo de riesgo) y 61 personas sin antecedente de contacto con garrapatas ni con perros con EC (grupo control). Se aplicó encuesta sobre factores de riesgo e historia de cuadros sugerentes de ehrlichiosis/anaplasmosis al grupo de riesgo. En ambos grupos se determinó presencia de IgG anti-Anaplasma sp. Resultados: Se encontró significativa mayor prevalencia de anticuerpos anti-Anaplasma sp en el grupo de riesgo que en el grupo control (18,5 versus 3,3 por ciento), p < 0,005. No se encontraron factores de riesgo asociados a sero-positividad, ni personas con historia sugerente de ehrlichiosis/anaplasmosis clínica. Noventa y cuatro por ciento de las viviendas del grupo de riesgo presentaba infestación por garrapatas. Discusión: Se evidencia mayor riesgo de exposición humana a Anaplasma sp en personas en contacto cercano con perros con EC y que habitan viviendas con infestación por garrapatas.

Guías clínicas de la enfermedad de Chagas 2006: parte VI: tratamiento antiparasitario de la enfermedad de Chagas / Guidelines for the Chagas disease: part VI: antiparasitic treatment for Chagas disease

As expert consensus has been arisen about universal antiparasitic treatment for all patients infected with Trypanosoma cruzi, most important drugs licensed for Chagas disease treatment are reviewed: nifurtimox and benznidazol, their mechanisms of action, doses, treatment schedules, adverse effects and contraindications. Two other drugs used for Chagas disease treatment, for which a Chilean experience may be exhibited, are allopurinol and itraconazole. Indications for treatment of Chagas disease in immunocompetent patients and inmunocompromised hosts are detailed. This chapter refers besides to the evaluation and monitoring of antiparasitic therapy in inmunocompromised patients, the availability of drugs and includes various forms facsímiles suggested to perform clinical and laboratory follow up of patients that undergo treatment, indicating the prescribed drug, adverse effects and time of follow up.

Con el consenso de expertos de que todo paciente infectado con Trypanosoma cruzi debiera recibir tratamiento anti-parasitario, se revisan los principales medicamentos aprobados para la enfermedad de Chagas: nifurtimox y benznidazol, sus mecanismos de acción, dosis, duración del tratamiento, efectos adversos y contraindicaciones. Se mencionan otros dos medicamentos utilizados en el tratamiento, en el que existe alguna experiencia nacional, como son allopurinol e itraconazol. Se revisan las indicaciones de tratamiento de la enfermedad de Chagas en personas inmuno-competentes y las indicaciones de tratamiento en hospederos inmunodeprimidos. Este capítulo finaliza abordando la evaluación y monitorización de la terapia antiparasitaria en inmunodeprimidos, la disponibilidad de medicamentos e incluye facsímiles de formularios sugeridos para realizar el seguimiento clínico y de laboratorio de los pacientes que son sometidos a tratamiento, indicando el fármaco utilizado, los efectos adversos y el tiempo de seguimiento.

Guías clínicas de la enfermedad de Chagas 2006: parte V: diagnóstico de laboratorio / Guidelines for the Chagas disease: part V: laboratory diagnosis of Chagas disease

In this fifth part of Guidelines for Chagas disease, diagnostic techniques for Trypanosoma cruzi infection in humans are reviewed, the interpretation of laboratory results and an algorithm for laboratory diagnosis in immunocompetent hosts are presented. Chagas disease may be diagnosed by three kinds of techniques: direct, which allow detect the presence of the parasite in different kind of samples; indirect, based on the search of immune specific response against T. cruzi antigens and molecular, which detect parasite genetic material. Direct techniques are utilized mamly in acute phase of disease, as the parasite is present in blood of infected host. These techniques do not require be confirmed by other methods. For chronic undetermined phase and for symptomatic phase it is recommended to use indirect techniques; generally, immunoassay techniques (ELISA) that detect IgG antibodies directed against T. cruzi antigens are performed. As false positive results are possible, a positive or undetermined result must be confirmed by at least another technique (indirect immunofluorescence or indirect hemmaglutination). In Chile, confirmation of infection is performed by the Instituto de Salud Pública National Reference Laboratory or at surrogate centers. Molecular methods may be used to make the diagnosis in acute or chronic phase of infection, with more accuracy in the acute phase, and it is mainly recommended to diagnose vertical transmission of T. cruzi as early diagnosis of congenital infection increases the possibility to cure the sibling and besides it is a good marker to evalúate the effectiveness of treatment.

En esta quinta parte de las Guías Clínicas de enfermedad de Chagas, se revisa el diagnóstico de la infección por Trypanosona cruzi en humanos, la interpretación de los resultados y un algoritmo de diagnóstico de laboratorio en inmunocompetentes. La enfermedad de Chagas se puede diagnosticar por medio de tres tipos de técnicas: directas, que permiten evidenciar la presencia del parásito en diferentes tipos de muestras; indirectas, que corresponden a la búsqueda de anticuerpos específicos contra antígenos de T. cruzi y moleculares, basadas en la detección del material genético del parásito. Las técnicas directas se emplean, de preferencia, en la fase aguda de la enfermedad, donde es posible detectar al parásito circulando en el torrente sanguíneo de la persona infectada. Estas técnicas no requieren ser confirmadas por otros métodos. Para la fase crónica indeterminada y para la fase sintomática es recomendado el uso de las técnicas indirectas; generalmente se emplean técnicas de inmuno ensayo (ELISA) que detectan anticuerpos de tipo IgG contra antígenos de T. cruzi. Por la posibilidad de reacciones falsas positivas, la recomendación es que los resultados positivos o indeterminados sean confirmados con, a lo menos, otra técnica diferente (inmunofluorescencia indirecta o hemaglutinación indirecta). En Chile la confirmación es realizada por el Laboratorio Nacional de Referencia del Instituto de Salud Pública y los centros autorizados por éste. Los métodos moleculares pueden ser empleados para el diagnóstico en fase aguda o crónica, teniendo mayor rendimiento en la primera, y su uso es recomendado principalmente como apoyo para la pesquisa de hijos de madres infectadas en la transmisión transplacentaria de la infección donde el diagnóstico precoz aumenta las posibilidades de cura del niño y es un buen marcador para evaluar el éxito del tratamiento.

Guías clínicas de la enfermedad de Chagas: Parte III. Enfermedad de Chagas en donantes de banco de sangre / Guidelines for chagas disease: Part III. Chagas disease in donors to blood banks

In this chapter it is emphasized the importance to guarantee safety and high quality blood transfusions. Besides, the following topics are analyzed: the importance of Trypcmosoma cruzi infection acquired by blood transfusions, the obligatory screening implemented in Chilean blood banks and serological diagnostic techniques used that for, the seroprevalence observed, the importance to confirm results and methods recommended in this purpose and, to notify the donor once the infection is confirmed. In addition a facsímil of a letter used to notify the positive donor is included as guidelines to make advice after, attaching a pro-forma of clinical-epidemiological registration to refer the donor to medical evaluation and treatment.

En este capítulo se establece la importancia de otorgar seguridad desde el punto de vista biológico y garantizar transfusiones de calidad y sin agentes infectantes detectables. Se analiza la importancia de la infección por Trypanosoma cruzi a través de transfusión sanguínea, el tamizaje obligatorio que se efectúa en Chile y las técnicas serológicas empleadas, la seroprevalencia encontrada en los bancos de sangre, la importancia de la confirmación y las técnicas empleadas y, la notificación al donante una vez confirmada la infección. Se acompaña de una carta tipo de notificación al donante positivo y una interesante guía para efectuar la consejería que debe seguir a la notificación, adjuntándose un formato de una ficha clínico-epidemiológica para su derivación a médico para estudio y tratamiento.

Guías clínicas de la enfermedad de Chagas: Parte IV. Enfermedad de Chagas en pacientes inmunocomprometidos / Guidelines for chagas disease: Part IV. Chagas disease in immune compromissed patients

A summary of different kind of immune supressed hosts and the importance of Tryponosoma cruzi infection in this group of patients is presented. Then, most relevant aspects of immune compromised host-parasite interaction are analyzed such as the moment of acquiring the infection, immune compromise level, mechanisms of acquisition the infection and geographic region. Clinical features of primary infection and reactivation of infection in chronic Chagasic patients are described making especial emphasis in solid organ transplant and BMT. Chagas disease in AIDS patients is discussed including its treatment, follow up, monitoring the immune compromise level and prophylaxis.

Se revisa someramente los diferentes tipos de inmu-osupresión y la importancia de la infección por Trypa-nosoma cruzi en este tipo de pacientes. Se analizan los aspectos más relevantes de la relación hospedero inmunocomprometido-r. cruzi, tales como el momento de la infección, grado de inmunocompromiso, mecanismos de adquisición de la infección y área geográfica. Se presenta el cuadro clínico en el caso de primoinfección, como así también en la reactivación de la infección en pacientes chagásicos crónicos, haciéndose hincapié en el trasplante de órganos sólidos y precursores hematopoyéticos. Mención especial se hace de la enfermedad de Chagas en pacientes con SIDA, destacando el cuadro clínico y enfatizando en su tratamiento, seguimiento, monitorización del nivel de su compromiso inmunológico y profilaxis.

Guías clínicas de la enfermedad de Chagas: Parte I. Introducción y epidemiología / Guidelines for the Chagas disease: Part I. Introduction and epidemiology

La existencia natural de esta zoonosis vectorial y el desarrollo de iniciativas en la Región de las Americas desde 1991 para controlar la Enfermedad de Chagas, hicieron necesario la elaboración de este documento para actualizar los conocimientos sobre esta materia y de este modo presentar una guía para el equipo de salud en Chile, puesto que es un problema de Salud Pública que debe ser abordado de forma integral. Se presenta la definición de Enfermedad de Chagas y su clasificación de acuerdo a la clasificación internacional de enfermedades (CIÉ 10). Se comenta en forma concisa y breve su importancia general, la importancia como carga de enfermedad, se analiza la distribución del vector, la magnitud del problema en Chile, su reservorio, las características del parásito y, sus mecanismos de transmisión. Se establece la definición de caso sospechoso agudo y confirmado para Chile, la situación epidemiológica en el país y un breve análisis costo beneficio del problema.

The natural existence of this vectorial zoonosis and the development since 1991 of initiatives in the American Region in order to control Chagas Disease, did necessary to prepare this document to update the knowledge about the disease and to exhibit guidelines for healthcare workers in Chile, as Chagas disease is a public health problem that needs to be attended in an integral way. A definition for Chagas disease and its classification according to the international classification of diseases (ICD 10) are presented. The general importance and disease load are concise and briefly commented, while the vector geographic distribution, the magnitude in Chile, its reservoir, the parasite main characteristics and its transmission mechanisms are reviewed. A definition for acute suspected and confirmed cases is given, and the epidemiological situation in Chile and a brief cost-benefit analysis of Chagas disease are presented.

Guías clínicas de la enfermedad de Chagas: Parte II. Enfermedad de Chagas en el adulto, la infancia y adolescencia / Guidelines for the Chagas disease: Part II. Chagas disease in adults, infancy and adolescence

Se describen las distintas etapas de la enfermedad en el adulto: aguda, indeterminada o latente y crónica. Se menciona cómo se realiza el diagnóstico etiológico y la indicación de tratamiento. En la etapa crónica, cuando existe compromiso cardíaco así como también digestivo (esófago o colon), se mencionan los síntomas y signos, la evolución, los exámenes de apoyo diagnóstico y el tratamiento. Se analiza la enfermedad de Chagas congénita desde su prevalencia en la embarazada, la etapa de la enfermedad en la madre, las repercusiones de la transmisión del parásito sobre el producto de la concepción, la frecuencia de la transmisión, cómo se produce la infección del feto, la situación en embarazos sucesivos, hasta las consecuencias sobre el recién nacido, incluyendo la sintomatología cuando éste nace enfermo. Se comenta la concomitancia con la infección por virus de inmunodeficiencia humana. Las formas de presentación no vertical en la infancia y adolescencia no difieren de la enfermedad de Chagas en el adulto. Se menciona el diagnóstico directo e indirecto de la infección y se presenta un algoritmo del diagnóstico y seguimiento de la infección vertical por Tripanosoma cruzi.

The different stages of Chagas disease in adults: acute, undetermined or latent and chronic phases are described. This document contains guidelines for etiological diagnosis of Chagas disease and its treatment. In chronic phase, as cardiac and digestive system (esophagus and colon) are affected, symptoms and signs, evolution of the disease, laboratory analysis and treatment are described. The following topics in congenital Chagas disease are boarded: its prevalence in pregnant women, the importance of mother phase of disease, repercussions of the parasite transmission to the fetus, the frequency of transmission, how the infection to the fetus is produced, the importance of chronic infection in consecutive pregnancies, and clinical consequences to the newborn infant including symptoms of congenital disease. Concomitance with human immunodeficiency virus is commented. No vertically transmitted Chagas disease in infancy and adolescents has similar clinical manifestations as in adults. Direct and indirect laboratory tests of infection are described and an algorithm for diagnosis and follow up of vertical transmission of Trypccnosoma cruzi is presented.

Calidad de vida de adultos mayores pobres de viviendas básicas: Estudio comparativo mediante uso de WHOQoL-BREF / Quality of life of elderly subjects living in basic social dwellings

Background: In Chile, the government is providing basic dwellings to poor elderly subjects that do not have a place to live. These dwellings may be located in buildings or in codominiums. Aim: To assess the quality of life perception of elderly subjects whose dwellings are located in buildings or in condominiums. Material and methods: The brief version of the quality of life questionnaire designed for the elderly by the World Health Organization (WHOQoL-BREF) was applied to elderly subjects of seven poor communities of Metropolitan Santiago, that lived in basic dwellings located in buildings or condominiums. The questionnaire includes questions about physical, psychological, social relations and environment domains. Results: The questionnaire was answered by 124 elderly subjects aged 60 to 90 years, living in condominiums and 152 subjects aged 62 to 94 years, living in buildings. Satisfaction was of moderate or high level for physical, psychological and social relations domains. Those living in condominiums had a better satisfaction level in this last domain. The level of satisfaction of the environment domain was moderate and better for those living in condominiums. The perception of quality of life deteriorated along with age. Conclusions: Elderly subjects living in basic dwellings located in condominiums have a better quality of life perception than those living in buildings.

Asistencia ventricular derecha con bomba centrífuga / Right ventricular assistance with a centrifugal pump. Report of two cases

Acute right ventricular failure after cardiac surgery occurring in the first postoperative hours is associated with a bad prognosis. We have used a centrifugal pump either for ¡eft, right or biventricular assistance. However, the use of this device for pure right ventricular assistance is rare. We report a 30 year-old female undergoing a mitral valve replacement and a 42 year-old male undergoing a cardiac transplantation, who had a successful right ventricular assistance using a centrifugal pump, due to a failing right ventricle, as the result of insufficient myocardial protection and severe pulmonary hypertension. These two cases illustrate the value of the mechanical ventricular assist device for the treatment of right heart failure.

Cambio en las redes sociales de adultos mayores beneficiarios de programas de vivienda social en Chile / Changes in the social networks of older adults who are beneficiaries of public housing projects in Chile

OBJETIVOS: Identificar, comparar y analizar las redes sociales de dos grupos de adultos mayores pobres, beneficiarios de dos tipos de viviendas sociales, en términos de tipos de nodos, frecuencia y motivo del vínculo, antes y después del traslado a sus nuevos domicilios. MÉTODO: Se realizó un estudio descriptivo de beneficiarios de viviendas en edificio, o bien de viviendas en condominios. El universo en estudio fue el colectivo de personas asignatarias a viviendas en edificio (n = 152) y a viviendas en condominio (n = 124), entre 1998 y 2001, a las cuales se les aplicó una encuesta en su domicilio. RESULTADOS: La mayoría de los participantes en el estudio informaron que la asignación de la vivienda implicó para ellos mudarse a barrios distantes de su antiguo domicilio, lo que provocó, entre otras consecuencias, un cambio en sus redes sociales. Ambos grupos tienen, en general, redes sociales similares, constituyendo los hijos el principal nodo de apoyo, antes y después del cambio de domicilio. Después del traslado se redujeron los vínculos en general, excepto en el caso de los adultos de vivienda en edificio, quienes incrementaron levemente sus vínculos con los hijos y en forma destacada con personas con quienes tienen vínculos débiles y que no son propiamente familiares ni amigos. Los vínculos con las instituciones también disminuyeron, aunque en el caso de las instituciones de adultos mayores aumentaron, para los residentes en condominios de 28 por ciento a 65 por ciento, y para los asignatarios de edificios, de 31 por ciento a 45 por ciento. CONCLUSIONES: Se sugiere que en los programas semejantes al estudiado se tome en cuenta la importancia que revisten la conservación y el fortalecimiento de las redes sociales creadas antes del traslado, y que se fomente la generación de vínculos en el nuevo sitio de residencia.

OBJECTIVES: To identify, compare, and analyze the social networks of two groups of poor, older adults in two types of public housing projects in Chile, in terms of the types of relationships and the frequency and purpose of their interactions, before and after moving to their new homes. METHODS: A descriptive study was conducted of public housing beneficiaries in apartment buildings versus condominiums. The study pool was the group of people assigned to housing in buildings (n = 152) and condominiums (n = 124) from 1998 to 2001. A questionnaire was administered in their homes. RESULTS: Most study participants indicated that the move to public housing meant leaving their old neighborhood for a new one, a change that, among other consequences, produced changes in their social networks. In general, both groups have similar social networks, with their children being the strongest source of support, both before and after the move. After the move, social interaction generally decreased, except among the adults living in apartment buildings, for whom it increased slightly with family members, and in a superficial manner, with others who had weak connections and were neither friends nor family. Interactions with establishments also decreased, although interactions with senior services increased for the condo residents from 28 percent to 65 percent and for apartment residents from 31 percent to 45 percent. CONCLUSIONS: It is recommended that similar programs strive to preserve and strengthen the social networks in place prior to moving and encourage the formation of relationships in the new residences.

Anisakiasis en un paciente portadora de una pequeña hernia hiatal: Caso clínico / Anisakiasis in a patient with a small hiatal hernia: Report of one case

We describe the presence of anisakiasis in a patient who had a small hiatal hernia. A 60 year-old women presented general malaise, burning pain, flatulence, persistent nausea and abdominal distension during five days before consulting. She referred that she ate a dish of marinated raw fish with lemon and pepper ("cebiche") and after a few hours the symptoms began. An esophagogastroscopy showed a white colour larva of approximately three cm with the cephalic end partially adhered and localized in the mucosa of the hiatal hernia. During the procedure the worm was easily extracted. The morphologic study of the specimen identified it as a stage IV larva of Pseudoterranova sp. The clinical condition of the patient improved after the extraction of the parasite.

Utilidad de la terapia trombolítica con estreptokinasa a dosis baja en infarto agudo del miocardio / Usefulness of thrombolytic therapy with low doses of streptokinase in acute myocardial infarction

Background: The optimal dose of Streptokinase in the treatment of acute myocardial infarction is not well established. Apparently, the thrombolytic efficacy would not increase with doses over 750.000 units. Aim: To compare the effectiveness and safety of treatment with low doses of Streptokinase, ranging from 500.000 to 750.000 units, in patients with ST elevation acute myocardial infarction. Patients and methods: From September 1993 to September 1998, the GEMI register of patients with acute myocardial infarction, was carried out in 37 hospitals, incorporating 4,938 patients. Of these, 1,631 patients received streptokinase. According to the administered dose of Streptokinase, patients were divided in two groups: 1,465 patients who received 1.5 millions U in 60 minutes (classical therapy group), and 166 patients with ischemic chest discomfort and either ST-segment elevation or left bundle-branch block on the electrocardiogram, who received 500.000 to 750.000 U streptokinase administered in no more than 30 minutes, with heparin, within 0 to 6 hours of symptom onset. Successful reperfusion, mortality, complications, and hospital outcome was evaluated in both groups. Results: The low dose group of patients had a better reperfusion criteria profile. No differences between groups were observed in patient evolution, mortality, maximum Killip classification, post myocardial infarction heart failure, ischemic complications, arrhythmias or mechanical complications. Conclusions: These results suggest that streptokinase in low doses is at least as effective as classical therapy, in the treatment of ST elevation acute myocardial infarction.